Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas: phase 2 study of the Italian Lymphoma Foundation.
Ferrario A, Pulsoni A, Olivero B, Rossi G, Vitolo U, Tedeschi A, Merli F, Rigacci L, Stelitano C, Goldaniga M, Mannina D, Musto P, Rossi F, Gamba E, Baldini L. Ferrario A, et al. Cancer. 2012 Aug 15;118(16):3954-61. doi: 10.1002/cncr.26708. Epub 2011 Dec 16. Cancer. 2012. PMID: 22179904 Free article. Clinical Trial.
Phase II fludarabine and cyclophosphamide for the treatment of indolent B cell non-follicular lymphomas: final results of the LL02 trial of the Gruppo Italiano per lo Studio dei Linfomi (GISL).
Ferrario A, Merli F, Luminari S, Stelitano C, Mannina D, Russo M, Mazza P, Marcheselli L, Goldaniga MC, Federico M, Baldini L; Gruppo Italiano per lo Studio dei Linfomi. Ferrario A, et al. Ann Hematol. 2011 Mar;90(3):323-30. doi: 10.1007/s00277-010-1067-1. Epub 2010 Sep 17. Ann Hematol. 2011. PMID: 20848104 Clinical Trial.
A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias.
Goldaniga M, Ferrario A, Cortelazzo S, Guffanti A, Pavone E, Ambrosetti A, Marcheselli L, Rossi F, Luminari S, Rossi A, Cro L, Federico M, Lambertenghi Deliliers G, Baldini L. Goldaniga M, et al. Among authors: ferrario a. Am J Hematol. 2008 May;83(5):349-54. doi: 10.1002/ajh.21065. Am J Hematol. 2008. PMID: 18186522 Free article.
Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi.
Merli M, Luminari S, Farina L, Cocito F, Defrancesco I, Gini G, Arcari A, Scapinello G, Gentile M, Goldaniga M, Loseto G, Cencini E, Greco A, Molinari AL, Ferrario A, Bianchi B, Mora B, Bertù L, Saturni V, Bergamini F, Fabbri N, Rossi FG, Bolis S, Passamonti F, Arcaini L. Merli M, et al. Among authors: ferrario a. Bone Marrow Transplant. 2020 Dec;55(12):2350-2353. doi: 10.1038/s41409-020-0967-5. Epub 2020 Jun 15. Bone Marrow Transplant. 2020. PMID: 32541690 No abstract available.
Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi.
Storti S, Spina M, Pesce EA, Salvi F, Merli M, Ruffini A, Cabras G, Chiappella A, Angelucci E, Fabbri A, Liberati AM, Tani M, Musuraca G, Molinari A, Petrilli MP, Palladino C, Ciancia R, Ferrario A, Gasbarrino C, Monaco F, Fraticelli V, De Vellis A, Merli F, Luminari S. Storti S, et al. Among authors: ferrario a. Haematologica. 2018 Aug;103(8):1345-1350. doi: 10.3324/haematol.2017.186569. Epub 2018 May 10. Haematologica. 2018. PMID: 29748444 Free PMC article. Clinical Trial.
The clinical and biological features of a series of immunophenotypic variant of B-CLL.
Cro L, Ferrario A, Lionetti M, Bertoni F, Zucal N N, Nobili L, Fabris S, Todoerti K, Cortelezzi A, Guffanti A, Goldaniga M, Marcheselli L, Neri A, Lambertenghi-Deliliers G, Baldini L. Cro L, et al. Among authors: ferrario a. Eur J Haematol. 2010 Aug;85(2):120-9. doi: 10.1111/j.1600-0609.2010.01454.x. Epub 2010 Apr 8. Eur J Haematol. 2010. PMID: 20408870
How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia.
Deodato M, Frustaci AM, Sportoletti P, Laurenti L, Murru R, Visentin A, Reda G, Mauro FR, Quaresmini G, Vanazzi A, Vitale C, Orsucci L, Massaia M, Sanna A, Motta M, Ibatici A, Ferrarini I, Borella C, Varettoni M, Tani M, Marinoni S, Ferrario A, Zamprogna G, Montillo M, Tedeschi A. Deodato M, et al. Among authors: ferrario a. Leuk Lymphoma. 2022 Aug;63(8):1985-1988. doi: 10.1080/10428194.2022.2053532. Epub 2022 Mar 27. Leuk Lymphoma. 2022. PMID: 35343363 No abstract available.
210 results